Author

T. Kalber

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:benchmarking· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1 Organism:mouse· 1

Frequent Co-Authors

A. Arenas-Pinto· 1 shared A. Cavedon· 1 shared A. Chakrapani· 1 shared A. Frassetto· 1 shared A. G. Schatzlein· 1 shared A. Milewska· 1 shared A. Morris· 1 shared C. Clark· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Arenas-Pinto

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The incidence of movement disorders increases with age and contrasts with subtle and limited neuroimaging abnormalities in argininosuccinic aciduria.

S. Gurung, S. Karamched, D. P. Perocheau, K. Seunarine, T. Balwin, L. Touramanidou, C. Duff, N. Elkhateeb, K. Stepien, R. Sharma, A. Morris, T. Hartley, L. Crowther, S. Grunewald, M. Cleary, , J. Baruteau

This study investigates movement disorders in argininosuccinic aciduria (ASA), finding they increase with age and show specific neuroimaging abnormalities not seen in mouse models.

bioRxiv · Oct 10, 2023 · PreprintGenetics

SARS-CoV-2 inhibition in human airway epithelial cells using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray

K. Pyrc, A. Milewska, E. B. Duran, P. Botwina, R. Lopes, A. Arenas-Pinto, M. Badr, R. Mellor, T. Kalber, D. Fernandez-Reyes, A. G. Schatzlein, I. F. Uchegbu

This paper demonstrates that GCPQ, a mucoadhesive chitosan derivative, reduces SARS-CoV-2 infectivity in cell cultures and shows promising nasal retention in mice, supporting its potential as a nasal spray for COVID-19 prevention.

bioRxiv · Dec 10, 2020 · PreprintPharmacology & Toxicology